Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYAIM ImmunoTech Announces IRB Approval to Enroll COVID-19 ‘Long Haulers’ in the AMP-511 ME/CFS Clinical Trial of AmpligenPREV STORYGenerex Subsidiary NuGenerex Immuno-Oncology Announces World Class Scientific Advisory Board Appointments for its COVID-19 Vaccine Development Program